Parplus Partners’s Colgate-Palmolive CL Stock Holding History

Parplus Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,191	Closed	-$220K	–	36
2019 Q4	$220K	Buy	+3,191	New	+$218K	0.04%	138

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Parplus Partners's CL Position: Q1 2020 in Review

Parplus Partners sold out of Colgate-Palmolive (CL) in Q1 2020, closing a stake of 3,191 shares — an estimated $220K sold.

Parplus Partners first reported a position in CL in Q4 2019 and held it in 1 quarter. The position peaked at $220K in Q4 2019. 1,493 funds tracked by Wall St. Rank hold CL as of Q1 2020.

Parplus Partners reported no remaining Colgate-Palmolive position as of Q1 2020 after selling out during the quarter.
Parplus Partners sold 3,191 Colgate-Palmolive shares in Q1 2020, an estimated $220K.
Parplus Partners first reported a position in Colgate-Palmolive in Q4 2019 and held it in 1 quarter.
Parplus Partners's Colgate-Palmolive position peaked at $220K in Q4 2019.
1,493 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2020.

Based on Parplus Partners's 13F filing for Q1 2020, filed 14 May 2020.